[HTML][HTML] Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade
R Yang, S Elsaadi, K Misund, P Abdollahi… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background PD1/PDL1-directed therapies have been unsuccessful for multiple myeloma
(MM), an incurable cancer of plasma cells in the bone marrow (BM). Therefore, other …
(MM), an incurable cancer of plasma cells in the bone marrow (BM). Therefore, other …
PRL‐3 induces a positive signaling circuit between glycolysis and activation of STAT1/2
EN Vandsemb, MB Rye, IJ Steiro, S Elsaadi… - The FEBS …, 2021 - Wiley Online Library
Multiple myeloma (MM) is an incurable hematologic malignancy resulting from the clonal
expansion of plasma cells. MM cells are interacting with components of the bone marrow …
expansion of plasma cells. MM cells are interacting with components of the bone marrow …
[HTML][HTML] Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration
MA Hjort, H Hov, P Abdollahi, EN Vandsemb… - … Hematology & Oncology, 2018 - Springer
Background Phosphatase of regenerating liver-3 (PRL-3) is implicated in oncogenesis of
hematological and solid cancers. PRL-3 expression increases metastatic potential …
hematological and solid cancers. PRL-3 expression increases metastatic potential …
[HTML][HTML] A patient with minimal myeloma treatment who survived for 20 years
AD Behsen, EN Vandsemb, TS Slørdahl… - …, 2024 - ncbi.nlm.nih.gov
We describe a patient who lived for 20 years after a strategy of minimal myeloma treatment.
If treated according to current treatment algorithms, this patient would have been heavily …
If treated according to current treatment algorithms, this patient would have been heavily …
The oncogenic role of PRL-3 in multiple myeloma through regulation of Src kinase family members
P Abdollahi, EN Vandsemb, MA Hjort, K Misund… - Cancer Research, 2016 - AACR
Introduction: Phosphatase of regenerating liver 3 (PRL-3) is a dual specificity phosphatase
and its up-regulation in cancer cells is related to poor prognosis. We have previously …
and its up-regulation in cancer cells is related to poor prognosis. We have previously …
The influence of PRL3 on the IL-6 pathway in multiple myeloma: an explorative analysis using transcriptomics and proteomics
EN Vandsemb - 2017 - ntnuopen.ntnu.no
BACKGROUND: Multiple myeloma (MM) is an incurable malignancy of plasma cells. So far,
blocking single growth factors, such as IL-6, has not led to improved patient survival in MM …
blocking single growth factors, such as IL-6, has not led to improved patient survival in MM …
[HTML][HTML] Vedvarende hikke etter perforert kolecystitt
JE Olsen, EN Vandsemb, MA Treider… - Tidsskrift for Den …, 2024 - tidsskriftet.no
Vedvarende hikke etter perforert kolecystitt | Tidsskrift for Den norske legeforening Hopp til
hovedinnhold Veksle navigasjon Artikler Fagområder Utgaver Podkast Forfatterveiledning …
hovedinnhold Veksle navigasjon Artikler Fagområder Utgaver Podkast Forfatterveiledning …